jan 1, 1998 - Trastuzumab
Description:
For the treatment of women with HER2-positive metastatic breast cancer, the Food and Drug Administration (FDA) recommends trastuzumab, a monoclonal antibody that inhibits cancer cells that overproduce the HER2 protein.
Added to timeline:
Date: